|
1
|
Sellares J, de Freitas DG, Mengel M, Reeve
J, Einecke G, Sis B, Hidalgo LG, Famulski K, Matas A and Halloran
PF: Understanding the causes of kidney transplant failure: The
dominant role of antibody-mediated rejection and nonadherence. Am J
Transplant. 12:388–399. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Abramowicz D, Oberbauer R, Heemann U,
Viklicky O, Peruzzi L, Mariat C, Crespo M, Budde K and Oniscu GC:
Recent advances in kidney transplantation: A viewpoint from the
descartes advisory board. Nephrol Dial Transplant. 33:1699–1707.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Loupy A and Lefaucheur C:
Antibody-mediated rejection of solid-organ allografts. N Engl J
Med. 379:1150–1160. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Muczynski KA, Ekle DM, Coder DM and
Anderson SK: Normal human kidney HLA-DR-expressing renal
microvascular endothelial cells: Characterization, isolation, and
regulation of MHC class II expression. J Am Soc Nephrol.
14:1336–1348. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Thomas KA, Valenzuela NM and Reed EF: The
perfect storm: HLA antibodies, complement, FcγRs, and endothelium
in transplant rejection. Trends Mol Med. 21:319–329. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Katsuma A, Yamakawa T, Nakada Y, Yamamoto
I and Yokoo T: Histopathological findings in transplanted kidneys.
Renal Replacement Therapy. 3:62017. View Article : Google Scholar
|
|
7
|
Jindra PT, Jin YP, Rozengurt E and Reed
EF: HLA class I antibody-mediated endothelial cell proliferation
via the mTOR pathway. J Immunol. 180:2357–2366. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jin YP, Valenzuela NM, Ziegler ME,
Rozengurt E and Reed EF: Everolimus inhibits Anti-HLA I
antibody-mediated endothelial cell signaling, migration and
proliferation more potently than sirolimus. Am J Transplant.
14:806–819. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Salehi S, Sosa RA, Jin YP, Kageyama S,
Fishbein MC, Rozengurt E, Kupiec-Weglinski JW and Reed EF:
Outside-in HLA class I signaling regulates ICAM-1 clustering and
endothelial cell-monocyte interactions via mTOR in transplant
antibody-mediated rejection. Am J Transplant. 18:1096–1109. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li F, Rao P, Hong L, Fishbein MC, Gjertson
DW and Reed EF: OR49 effect of everolimus immunotherapy on
HLA-antibody mediated activation of endothelial cells in heart
transplantation. Hum Immunol. 78:462017. View Article : Google Scholar
|
|
11
|
Laplante M and Sabatini DM: mTOR signaling
at a glance. J Cell Sci. 122:3589–3594. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Saran U, Foti M and Dufour JF: Cellular
and molecular effects of the mTOR inhibitor everolimus. Clin Sci
(Lond). 129:895–914. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Castilho BA, Shanmugam R, Silva RC, Ramesh
R, Himme BM and Sattlegger E: Keeping the eIF2 alpha kinase Gcn2 in
check. Biochim Biophys Acta. 1843:1948–1968. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Munn DH, Sharma MD, Baban B, Harding HP,
Zhang Y, Ron D and Mellor AL: GCN2 kinase in T cells mediates
proliferative arrest and anergy induction in response to
indoleamine 2,3-dioxygenase. Immunity. 22:633–642. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Eleftheriadis T, Pissas G, Antoniadi G,
Spanoulis A, Liakopoulos V and Stefanidis I: Indoleamine
2,3-dioxygenase increases p53 levels in alloreactive human T cells,
and both indoleamine 2,3-dioxygenase and p53 suppress glucose
uptake, glycolysis and proliferation. Int Immunol. 26:673–684.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Eleftheriadis T, Pissas G, Antoniadi G,
Liakopoulos V and Stefanidis I: Indoleamine 2,3-dioxygenase
depletes tryptophan, activates general control non-derepressible 2
kinase and down-regulates key enzymes involved in fatty acid
synthesis in primary human CD4+ T cells. Immunology.
146:292–300. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pines M and Spector I: Halofuginone-the
multifaceted molecule. Molecules. 20:573–594. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sundrud MS, Koralov SB, Feuerer M, Calado
DP, Kozhaya AE, Rhule-Smith A, Lefebvre RE, Unutmaz D, Mazitschek
R, Waldner H, et al: Halofuginone inhibits TH17 cell
differentiation by activating the amino acid starvation response.
Science. 324:1334–1338. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Carlson TJ, Pellerin A, Djuretic IM,
Trivigno C, Koralov SB, Rao A and Sundrud MS: Halofuginone-induced
amino acid starvation regulates Stat3-dependent Th17 effector
function and reduces established autoimmune inflammation. J
Immunol. 192:2167–2176. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yamakuchi M, Kirkiles-Smith NC, Ferlito M,
Cameron SJ, Bao C, Fox-Talbot K, Wasowska BA, Baldwin WM III, Pober
JS and Lowenstein CJ: Antibody to human leukocyte antigen triggers
endothelial exocytosis. Proc Natl Acad Sci USA. 104:1301–1306.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Naemi FM, Carter V, Kirby JA and Ali S:
Anti-donor HLA class I antibodies: Pathways to endothelial cell
activation and cell-mediated allograft rejection. Transplantation.
96:258–266. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jin YP, Singh RP, Du ZY, Rajasekaran AK,
Rozengurt E and Reed EF: Ligation of HLA class I molecules on
endothelial cells induces phosphorylation of Src, paxillin, and
focal adhesion kinase in an actin-dependent manner. J Immunol.
168:5415–5423. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rostaing L, Christiaans MH, Kovarik JM and
Pascual J: The pharmacokinetics of everolimus in de novo kidney
transplant patients receiving tacrolimus: An analysis from the
randomized ASSET study. Ann Transplant. 19:337–345. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fadeel B and Orrenius S: Apoptosis: A
basic biological phenomenon with wide-ranging implications in human
disease. J Intern Med. 258:479–517. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang X, Rozengurt E and Reed EF: HLA
class I molecules partner with integrin β4 to stimulate endothelial
cell proliferation and migration. Sci Signal. 3:ra852010.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu L, Chen L, Chung J and Huang S:
Rapamycin inhibits F-actin reorganization and phosphorylation of
focal adhesion proteins. Oncogene. 27:4998–5010. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Drolet MC, Desbiens-Brassard V, Roussel E,
Tu V, Couet J and Arsenault M: Blockade of the acute activation of
mTOR complex 1 decreases hypertrophy development in rats with
severe aortic valve regurgitation. Springerplus. 4:4352015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jiao Y, Li G, Li Q, Ali R, Qin L, Li W,
Qyang Y, Greif DM, Geirsson A, Humphrey JD and Tellides G: mTOR
(Mechanistic Target of Rapamycin) inhibition decreases
mechanosignaling, collagen accumulation, and stiffening of the
thoracic aorta in elastin-deficient mice. Arterioscler Thromb Vasc
Biol. 37:1657–1666. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lee FY, Zhen YY, Yuen CM, Fan R, Chen YT,
Sheu JJ, Chen YL, Wang CJ, Sun CK and Yip HK: The mTOR-FAK
mechanotransduction signaling axis for focal adhesion maturation
and cell proliferation. Am J Transl Res. 9:1603–1617.
2017.PubMed/NCBI
|
|
30
|
Sarbassov DD: Phosphorylation and
regulation of Akt/PKB by the Rictor-mTOR complex. Science.
307:1098–1101. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jacinto E, Facchinetti V, Liu D, Soto N,
Wei S, Jung SY, Huang Q, Qin J and Su B: SIN1/MIP1 Maintains
rictor-mTOR complex integrity and regulates Akt phosphorylation and
substrate specificity. Cell. 127:125–137. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Silva RC, Sattlegger E and Castilho BA:
Perturbations in actin dynamics reconfigure protein complexes that
modulate GCN2 activity and promote an eIF2 response. J Cell Sci.
129:4521–4533. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yang L, Froio RM, Sciuto TE, Dvorak AM,
Alon R and Luscinskas FW: ICAM-1 regulates neutrophil adhesion and
transcellular migration of TNF-alpha-activated vascular endothelium
under flow. Blood. 106:584–592. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kaizuka Y, Douglass AD, Varma R, Dustin ML
and Vale RD: Mechanisms for segregating T cell receptor and
adhesion molecules during immunological synapse formation in Jurkat
T cells. Proc Natl Acad Sci USA. 104:20296–20301. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kuokkanen E, Šuštar V and Mattila PK:
Molecular control of B cell activation and immunological synapse
formation. Traffic. 16:311–326. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Barber DF, Faure M and Long EO: LFA-1
contributes an early signal for NK cell cytotoxicity. J Immunol.
173:3653–3659. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hsu HT and Orange JS: Distinct
integrin-dependent signals define requirements for lytic granule
convergence and polarization in natural killer cells. Sci Signal.
7:pe242014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Valenzuela NM, Mulder A and Reed EF: HLA
class I antibodies trigger increased adherence of monocytes to
endothelial cells by eliciting an increase in endothelial
P-selectin and, depending on subclass, by engaging FcγRs. J
Immunol. 190:6635–6650. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Neefjes J, Jongsma ML, Paul P and Bakke O:
Towards a systems understanding of MHC class I and MHC class II
antigen presentation. Nat Rev Immunol. 11:823–836. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Bentall A, Cornell LD, Gloor JM, Park WD,
Gandhi MJ, Winters JL, Chedid MF, Dean PG and Stegall MD: Five-year
outcomes in living donor kidney transplants with a positive
crossmatch. Am J Transplant. 13:76–85. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Mestas J and Hughes CC: Of mice and not
men: Differences between mouse and human immunology. J Immunol.
172:2731–2738. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hayry P, von Willebrand E and Andersson
LC: Expression of HLA-ABC and -DR locus antigens on human kidney,
endothelial, tubular and glomerular cells. Scand J Immunol.
11:303–310. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Evans PR, Trickett LP, Smith JL, MacIver
AG, Tate D and Slapak M: Varying expression of major
histocompatibility complex antigens on human renal endothelium and
epithelium. Br J Exp Pathol. 66:79–87. 1985.PubMed/NCBI
|
|
44
|
Daar AS, Fuggle SV, Fabre JW, Ting A and
Morris PJ: The detailed distribution of mhc class II antigens in
normal human organs. Transplantation. 38:293–298. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Muczynski KA, Cotner T and Anderson SK:
Unusual expression of human lymphocyte antigen class II in normal
renal microvascular endothelium. Kidney Int. 59:488–497. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
McDouall RM, Yacoub M and Rose ML:
Isolation, culture, and characterisation of MHC class II-positive
microvascular endothelial cells from the human heart. Microvasc
Res. 51:137–152. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Orandi BJ, Alachkar N, Kraus ES, Naqvi F,
Lonze BE, Lees L, Van Arendonk KJ, Wickliffe C, Bagnasco SM,
Zachary AA, et al: Presentation and outcomes of C4d-negative
antibody-mediated rejection after kidney transplantation. Am J
Transplant. 16:213–220. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Loupy A, Lefaucheur C, Vernerey D, Prugger
C, Duong van Huyen JP, Mooney N, Suberbielle C, Frémeaux-Bacchi V,
Méjean A, Desgrandchamps F, et al: Complement-binding anti-HLA
antibodies and kidney-allograft survival. N Engl J Med.
369:1215–1226. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Merle NS, Church SE, Fremeaux-Bacchi V and
Roumenina LT: Complement System Part I-molecular mechanisms of
activation and regulation. Front Immunol. 6:2622015. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Matsushima K, Baldwin ET and Mukaida N:
Interleukin-8 and MCAF: Novel leukocyte recruitment and activating
cytokines. Chem Immunol. 51:236–265. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Deshmane SL, Kremlev S, Amini S and Sawaya
BE: Monocyte chemoattractant Protein-1 (MCP-1): An overview. J
Interferon Cytokine Res. 29:313–326. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Meli A, Carter T, McCormack A, Hannah MJ
and Rose ML: Antibody alone is not a stimulator of exocytosis of
weibel-palade bodies from human endothelial cells. Transplantation.
94:794–801. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Hassan MI, Saxena A and Ahmad F: Structure
and function of von Willebrand factor. Blood Coagul Fibrinolysis.
23:11–22. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Prud'homme GJ: Pathobiology of
transforming growth factor beta in cancer, fibrosis and immunologic
disease, and therapeutic considerations. Lab Invest. 87:1077–1091.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Hart A, Smith JM, Skeans MA, Gustafson SK,
Stewart DE, Cherikh WS, Wainright JL, Boyle G, Snyder JJ, Kasiske
BL and Israni AK: Kidney. Am J Transplant. 16 (Suppl 2):S11–S46.
2016. View Article : Google Scholar
|
|
56
|
Berger SP, Sommerer C, Witzke O, Tedesco
H, Chadban S, Mulgaonkar S, Qazi Y, de Fijter JW, Oppenheimer F,
Cruzado JM, et al: Two-year outcomes in de novo renal transplant
recipients receiving everolimus-facilitated calcineurin inhibitor
reduction regimen from the TRANSFORM study. Am J Transplant.
19:3018–3034. 2019. View Article : Google Scholar : PubMed/NCBI
|
